Veminsyn Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 114

Employees

  • Latest Deal Type
  • Series B2

  • Investors
  • 13

Veminsyn General Information

Description

Manufacturer of synthetic biology-based active ingredients intended for cosmetic and personal care applications. The company offers protein engineering, plant cell bioreactor systems, and high-throughput screening technologies to produce novel bioactive compounds, serving the skincare and beauty market to access domestically developed ingredient alternatives that support anti-aging, enhance skin health, and expand formulation possibilities through scalable and customizable biomanufacturing.

Contact Information

Formerly Known As
Beijing Weiming Shiguang Biotechnology, Beijing Wuming Shiguang Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 3
  • Number 112 Jinjiadu Road, Yuhang District
  • Hangzhou, Zhejiang 311100
  • China
+86 0571
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Corporate Office
  • 3rd Floor, Building 3
  • Number 112 Jinjiadu Road, Yuhang District
  • Hangzhou, Zhejiang 311100
  • China
+86 0571

Veminsyn Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Veminsyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B2) 15-Aug-2026 Completed Generating Revenue
5. Early Stage VC (Series B1) 15-Sep-2025 Completed Generating Revenue
4. Early Stage VC (Series B) 23-May-2025 Completed Generating Revenue
3. Early Stage VC (Series A1) 18-Dec-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Oct-2022 $14.1M $21.9M Completed Generating Revenue
1. Seed Round 03-Nov-2021 $7.79M $7.79M Completed Startup
To view Veminsyn’s complete valuation and funding history, request access »

Veminsyn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Veminsyn Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guoxiong Capital Venture Capital Minority
HaiBang Ventures Venture Capital Minority
Hangzhou Capital Government Minority
Huatai Capital Venture Capital Minority
Huatai Zijin Investment Corporate Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Veminsyn FAQs

  • When was Veminsyn founded?

    Veminsyn was founded in 2021.

  • Where is Veminsyn headquartered?

    Veminsyn is headquartered in Hangzhou, China.

  • What is the size of Veminsyn?

    Veminsyn has 114 total employees.

  • What industry is Veminsyn in?

    Veminsyn’s primary industry is Biotechnology.

  • Is Veminsyn a private or public company?

    Veminsyn is a Private company.

  • What is the current valuation of Veminsyn?

    The current valuation of Veminsyn is .

  • What is Veminsyn’s current revenue?

    The current revenue for Veminsyn is .

  • How much funding has Veminsyn raised over time?

    Veminsyn has raised $35.7M.

  • Who are Veminsyn’s investors?

    Guoxiong Capital, HaiBang Ventures, Hangzhou Capital, Huatai Capital, and Huatai Zijin Investment are 5 of 13 investors who have invested in Veminsyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process